More CKD patients with diabetes versus those without diabetes had their albumin-to-creatinine ratio (ACR) assessed (64.2 vs. 17.0%) or received an ACE inhibitor/ARB (78.3 vs. 58.1%) or statins (64.6 vs. 39.2%). This evidence concerns the gene ALB and diabetes mellitus.